Raymond James Financial Services Advisors, Inc. Revolution Medicines, Inc. Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 35,730 shares of RVMD stock, worth $1.51 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
35,730Holding current value
$1.51 Million% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding RVMD
# of Institutions
299Shares Held
179MCall Options Held
920KPut Options Held
1.06M-
Vanguard Group Inc Valley Forge, PA17.1MShares$722 Million0.01% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$567 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA13.2MShares$560 Million3.09% of portfolio
-
Wellington Management Group LLP Boston, MA10.8MShares$457 Million0.09% of portfolio
-
Janus Henderson Group PLC London, X09.48MShares$401 Million0.22% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $3.71B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...